Skip to main content

Mesenchymal Stem Cells for the Treatment of Hematological Malignancies

Role in Hematopoietic Stem Cell Transplantation and Bone Marrow Failure

  • Conference paper
  • 477 Accesses

Part of the book series: Ernst Schering Research Foundation Workshop ((3368,volume 11))

6.4 Conclusion

Allogeneic MSC have a fully therapeutic potential in HSCT and possibly in bone marrow failure. However, there are still some questions.

The therapeutic dose of MSC needed in clinics is still unknown. Repetitive infusion of MSC might be necessary to maintain the therapeutic effect and to get a sufficient level of chimerism. MSC are immunosuppressive, can induce tolerance, and decrease GVHD; actually these immunological effects might be deleterious on the graft versus tumor effect. The place of allogeneic MSC from unique donors needs to be evaluated. The place of genetically modified MSC in HSCT also needs to be evaluated.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Almeida-Porada G, Porada CD, Tran N, Zanjani ED (2000) Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 95:3620–3627

    PubMed  CAS  Google Scholar 

  • Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, Mclntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R (2002) Mesenchymal stem cells suppress lymphocyte proliferation and prolong skin graft survival in vivo. Exp Hematol 30:42–48

    Article  PubMed  Google Scholar 

  • Benshidoum M et al. Transplantation of human bone marrow stromal cells (MSC) into immunodeficient mice. The improvement of human hematopoiesis maintenance and the extent of tissue engraftment depend on the studied MSC subsets. Submitted

    Google Scholar 

  • Deans RJ, Moseley AB (2000) Mesenchymal stem cells and potential clinical uses. Exp Hematol 28:875–884

    Article  PubMed  CAS  Google Scholar 

  • Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A, Hoffman R (2001) Mesenchymal stem cells are capable of homing to the bone marrow of nonhuman primates following systemic infusion. Exp Hematol 29:244–255

    Article  PubMed  CAS  Google Scholar 

  • Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T lymphocyte proliferation induced by cellular or non specific mitogen stimuli. Blood 99:3838–3843

    Article  PubMed  Google Scholar 

  • Fouillard L, Benshidoum M, Bories D, Bonte H, Lopez M, Moseley AM, Smith A, Lesage S, Beaujean F, Thierry D, Gourmelon P, Najman A, Gorin NC (2003) Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe aplastic anemia improves stroma. Leukemia 17:474–476

    Article  PubMed  CAS  Google Scholar 

  • Gurevitch O, Prigozhina TB, Pugatsch T, Slavin S (1999) Transplantation of allogeneic or xenogenic bone marrow within the donor stromal microenvironment. Transplantation 68:1362–1368

    Article  PubMed  CAS  Google Scholar 

  • Holmberg LA, Seidel K, Leisenring W, Storb BT (1994) Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 84:3685–3690

    PubMed  CAS  Google Scholar 

  • Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WK, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK (1999) Transplantation and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313

    Article  PubMed  CAS  Google Scholar 

  • Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S (1994) Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune disease in MRL/ MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 152:3119

    PubMed  CAS  Google Scholar 

  • Jo DY, Rafii S, Hamada T, Moore MA (2000) Chemotaxis of primitive hematopoetic cells in response to stromal cell-derived factor 1. J Clin Invest 105:101–111

    Article  PubMed  CAS  Google Scholar 

  • Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM (2000) Rapid hematopoietic recovery after coinfusion of autologous blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high dose chemotherapy. J Clin Oncol 18:307–316

    PubMed  Google Scholar 

  • Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W (2002) Allogeneic mesenchymal stem cell infusion for the treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215–222

    Article  PubMed  Google Scholar 

  • Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implication for therapeutic use. Bone Marrow Transplant 16:557–564

    PubMed  CAS  Google Scholar 

  • Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, Flake AW (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282–1286

    Article  PubMed  CAS  Google Scholar 

  • Noort WA, Kruisselbrink AB, in’t Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MH, Lowik CW, Falkenburg JH, Willemze R, Fibbe WE (2002) Mesenchymal stem cells promote engraftment of human umbilical cord blood derived CD34+ cells in NOD-SCID mice. Exp Hematol 30:870–878

    Article  PubMed  Google Scholar 

  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  PubMed  CAS  Google Scholar 

  • Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–73

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fouillard, L. (2005). Mesenchymal Stem Cells for the Treatment of Hematological Malignancies. In: Keating, A., Dicke, K., Gorin, N., Weber, R., Graf, H. (eds) Regenerative and Cell Therapy. Ernst Schering Research Foundation Workshop, vol 11. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-26843-X_6

Download citation

  • DOI: https://doi.org/10.1007/3-540-26843-X_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22093-0

  • Online ISBN: 978-3-540-26843-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics